32. Meng, P., Dalal, H., Chen, Y., Brueffer, C., Gladchuk, S., Alcaide, M., ... & Saal, L. H. (2024). Digital PCR quantification of ultrahigh ERBB2 copy number identifies poor breast cancer survival after trastuzumab. npj Breast Cancer, 10(1), 1-10.

31. Meisser, S. S., Mitamura, Y., Altunbulakli, C., Bandier, J., Opstrup, M. S., Gadsbøll, A. S. Ø., ... & Bonefeld, C. M. (2024). Regulation of immune response genes in the skin of allergic and clinically tolerant individuals exposed to p‐phenylenediamine. Allergy.

30. Altunbulakli, C., Jimenez, D. G., Askmyr, D., Sobti, A., Swoboda, S., Greiff, L., & Lindstedt, M. (2023). Targeted spatial proteomic analysis of CD8+ T-and myeloid cells in tonsillar cancer. Frontiers in Oncology, 13.

29. Gerdtsson, A. S., de Matos Rodrigues, J., Eskelund, C. W., Husby, S., Grønbæk, K., Räty, R., ... & Ek, S. (2023). Overexpression of the key metabolic protein CPT1A defines mantle cell lymphoma patients with poor response to standard high-dose chemotherapy independent of MIPI and complement established high-risk factors. Haematologica, 108(4), 1092.

28. Jimenez, D. G., Altunbulakli, C., Swoboda, S., Sobti, A., Askmyr, D., Ali, A., Greiff, L. & Lindstedt, M. (2023). Single-cell analysis of myeloid cells in HPV+ tonsillar cancer. Frontiers in Immunology, 13, 1087843.

27. Kalliara, E., Belfrage, E., Gullberg, U., Drott, K., & Ek, S. (2023). Spatially Guided and Single Cell Tools to Map the Microenvironment in Cutaneous T-Cell Lymphoma. Cancers, 15(8), 2362.

26. Mosquim Junior, S., Siino, V., Rydén, L., Vallon-Christersson, J., Levander, L. (2022). Choice of High-Throughput Proteomics Method Affects Data Integration with Transcriptomics and the Potential Use in Biomarker Discovery. Cancers, 14(23).

25. Velickovic, K., Borrebaeck, C.A.K., Bendahl, P-O., Hegardt, C., Johnsson, P., Richter, C., Ryden, L., & Hallberg, I. (2022). One-year recovery from breast cancer: Importance of tumor and treatment-related factors, resilience, and socio-demographic factors for Health-Related Quality of Life. Frontiers in Oncology, 12.

24. De Alwis, R., Hansson, J., Lindgren, D., Schoch, S., Tejera, A., Scholtz, B., ... & Axelson, H. (2022). Size‑based isolation and detection of renal carcinoma cells from whole blood. Molecular and clinical oncology, 16(5), 1-11.

23. Siino, V., Ali, A., Accardi, G., Aiello, A., Ligotti, M. E., Mosquim Junior, S., ... & Vasto, S. (2022). Plasma proteome profiling of healthy individuals across the life span in a Sicilian cohort with long‐lived individuals. Aging Cell, 21(9), e13684.

22. Boraka, Ö., Klintman, M., & Rosendahl, A. H. (2022). Physical Activity and Long-Term Risk of Breast Cancer, Associations with Time in Life and Body Composition in the Prospective Malmö Diet and Cancer Study. Cancers, 14(8), 1960.

21. Governa, V., Talbot, H., Gonçalves de Oliveira, K., Cerezo-Magaña, M., Bång-Rudenstam, A., Johansson, M. C., ... & Belting, M. (2022). Landscape of surfaceome and endocytome in human glioma is divergent and depends on cellular spatial organization.PNAS, 119(9), e2114456119.

20. Lopez de Lapuente Portilla, A., Ekdahl, L., Cafaro, C., Ali, Z., Miharada, N., Thorleifsson, G., ... & Nilsson, B. (2022). Genome-wide association study on 13 167 individuals identifies regulators of blood CD34+ cell levels. Blood, The Journal of the American Society of Hematology, 139(11), 1659-1669.

19. Dalal, H., Dahlgren, M., Gladchuk, S., Brueffer, C., Gruvberger-Saal, S. K., & Saal, L. H. (2022). Clinical associations of ESR2 (estrogen receptor beta) expression across thousands of primary breast tumors. Scientific Reports, 12(1), 1-12.

18. Kopecky, J., Pérez, J. E., Eriksson, H., Visse, E., Siesjö, P., & Darabi, A. (2022). Intratumoral administration of the antisecretory peptide AF16 cures murine gliomas and modulates macrophage functions. Scientific Reports, 12(1), 1–12.

17. Ajore, R., Niroula, A., Pertesi, M., Cafaro, C., Thodberg, M., Went, M., Bao EL, Duran-Lozano, L. ... & Nilsson, B. (2022). Functional dissection of inherited non-coding variation influencing multiple myeloma risk. Nature Communications, 13(1), 1-15.

16. Lokhande, L., Kuci Emruli, V., Eskelund, C. W., Kolstad, A., Hutchings, M., Räty, R., ... & Ek, S. (2021). Serum proteome modulations upon treatment provides biological insight on response to treatment in relapsed mantle cell lymphoma. Cancer Reports, e1524.

15. Jimenez, D. G., Sobti, A., Askmyr, D., Sakellariou, C., Santos, S. C., Swoboda, S., ... & Lindstedt, M. (2021). Tonsillar Cancer with High CD8+ T-Cell Infiltration Features Increased Levels of Dendritic Cells and Transcriptional Regulation Associated with an Inflamed Tumor Microenvironment. Cancers, 13(21), 5341.

14. Sobti, A., Sakellariou, C., Nilsson, M., Schwartz, S., Olofsson, K., Rydell, R., ... & Forslund, O. (2021). Immune delineation of laryngeal papilloma reveals enhanced neutrophil associated gene profile. European Journal of Immunology, 51(10), 2535-2539.

13. Merrien, M., Wasik, A. M., Ljung, E., Morsy, M. H., de Matos Rodrigues, J., Carlsten, M., ... & Sander, B. (2021). Clinical and biological impact of SAMHD1 expression in mantle cell lymphoma. Virchows Archiv, 1-12.

12. Askmyr, D., Abolhalaj, M., Jimenez, D. G., Greiff, L., Lindstedt, M., & Lundberg, K. (2021). Pattern recognition receptor expression and maturation profile of dendritic cell subtypes in human tonsils and lymph nodes. Human Immunology, 82(12), 976-981.

11. Mukherjee, S., Sundfeldt, K., Borrebaeck, C. A., & Jakobsson, M. E. (2021). Comprehending the Proteomic Landscape of Ovarian Cancer: A Road to the Discovery of Disease Biomarkers. Proteomes, 9(2), 25.

10. Duran-Lozano, L., Thorleifsson, G., de Lapuente Portilla, A. L., Niroula, A., Went, M., Thodberg, M., ... & Nilsson, B. (2021). Germline variants at SOHLH2 influence multiple myeloma risk. Blood cancer journal, 11(4), 1-8.

9.  Rodrigues, J. M., Porwit, A., Hassan, M., Ek, S., & Jerkeman, M. (2021). Targeted genomic investigations in a population-based cohort of mantle cell lymphoma reveal novel clinically relevant targets. Leukemia & Lymphoma, 1-11.

8. Rodrigues, J.M., Nikkarinen, A., Hollander, P., Weibull, C.E., Räty, R., Kolstad, A., Amini, R.M., Porwit, A., Jerkeman, M., Ek, S. and Glimelius, I., 2021. Infiltration of CD163-, PD-L1-and FoxP3-positive cells adversely affects outcome in patients with mantle cell lymphoma independent of established risk factors. British Journal of Haematology, 93(3), 520-531.

7. Lokhande, L., Emruli, V. K., Kolstad, A., Hutchings, M., Räty, R., Jerkeman, M., & Ek, S. (2020). Immune-related protein signature in serum stratify relapsed mantle cell lymphoma patients based on risk. BMC cancer, 20(1), 1-13.

6. Nilsson, J. S., Sobti, A., Swoboda, S., Erjefält, J. S., Forslund, O., Lindstedt, M., & Greiff, L. (2020). Immune Phenotypes of Nasopharyngeal Cancer. Cancers, 12(11), 3428.

5. Gomez Jimenez, D., Carreira Santos, S., Greiff, L., Alm, K., & Lindstedt, M. (2020). Subpopulations of Organoid-Forming Cells Have Different Motility. Applied Sciences, 10(13), 4673.

4. Rodrigues, J. M., Hassan, M., Freiburghaus, C., Eskelund, C. W., Geisler, C., Räty, R., ... & Kwiecinska, A. (2020). p53 is associated with high‐risk and pinpoints TP53 missense mutations in mantle cell lymphoma. British Journal of Haematology.

3. Ramakrishnan, R., Peña-Martínez, P., Agarwal, P., Rodriguez-Zabala, M., Chapellier, M., Högberg, C., ... & Nilsson, B. (2020). CXCR4 Signaling Has a CXCL12-Independent Essential Role in Murine MLL-AF9-Driven Acute Myeloid Leukemia. Cell Reports, 31(8), 107684.

2. Velickovic, K., Rahm Hallberg, I., Axelsson, U., Borrebaeck, C. A., Rydén, L., Johnsson, P., & Månsson, J. (2020). Psychometric properties of the Connor-Davidson Resilience Scale (CD-RISC) in a non-clinical population in Sweden. Health and Quality of Life Outcomes, 18, 1-10.

1. Pérez, J. E., Kopecky, J., Visse, E., Darabi, A., & Siesjö, P. (2020). Convection-enhanced delivery of temozolomide and whole cell tumor immunizations in GL261 and KR158 experimental mouse gliomas. BMC cancer, 20(1), 1-12.